Performance of Ultra-Deep Pyrosequencing in Analysis of HIV-1 pol Gene Variation by Mild, Mattias et al.
Performance of Ultra-Deep Pyrosequencing in Analysis
of HIV-1 pol Gene Variation
Mattias Mild
1*
., Charlotte Hedskog
1., Johanna Jernberg
1, Jan Albert
1,2
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden, 2Clinical Microbiology, Karolinska University Hospital, Stockholm,
Sweden
Abstract
Introduction: Ultra-deep pyrosequencing (UDPS) has been used to detect minority variants within HIV-1 populations. Some
aspects of the quality and reproducibility of UDPS have been previously evaluated, but comprehensive studies are still
needed.
Principal Finding: In this study the UDPS technology (FLX platform) was evaluated by analyzing a 120 base pair fragment of
the HIV-1 pol gene from plasma samples from two patients and artificial mixtures of molecular clones. UDPS was performed
using an optimized experimental protocol and an in-house data cleaning strategy. Nine samples and mixtures were
analyzed and the average number of reads per sample was 19,404 (range 8,858–26,846). The two patient plasma samples
were analyzed twice and quantification of viral variants was found to be highly repeatable for variants representing .0.27%
of the virus population, whereas some variants representing 0.11–0.27% were detected in only one of the two UDPS runs.
Bland-Altman analysis showed that a repeated measurement would have a 95% likelihood to lie approximately within 60.5
log10 of the initial estimate. A similar level of agreement was observed for variant frequency estimates in forward vs. reverse
sequencing direction, but here the agreement was higher for common variants than for rare variants. UDPS following PCR
amplification with alternative primers indicated that some variants may be incorrectly quantified due to primer-related
selective amplification. Finally, the in vitro recombination rate during PCR was evaluated using artificial mixtures of clones
and was found to be low. The most abundant in vitro recombinant represented 0.25% of all UDPS reads.
Conclusion: This study demonstrates that this UDPS protocol results in low experimental noise and high repeatability,
which is relevant for future research and clinical use of the UDPS technology. The low rate of in vitro recombination
suggests that this UDPS system can be used to study genetic variants and mutational linkage.
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Introduction
In 2005 the first next generation sequencing (NGS) platform,
the Genome Sequencer 20 (GS20) from 454 Life Sciences [1],
was released and since then several other NGS platforms have
been introduced. In addition, several updates have been
released, which have increased the throughput and read length.
The major platforms used today include the 454 FLX and 454
Titanium from Roche, the SOLID platform from Applied
Biosystems and the Solexa platform from Illumina. SOLID and
Solexa generate reads which are 50–100 base pairs (bp) long.
The 454 FLX and Titanium platforms produce longer reads (300
and 500 bp, respectively). One application of NGS is sequencing
of many individual template molecules obtained from specific
gene fragments to study minority sequence variants and
haplotype composition. For this approach the amplicon
sequencing on the 454 platform, also called ultra-deep
pyrosequencing (UDPS), is well suited because of the longer
read lengths. The UDPS technology has been used to study
cancer-associated genes in humans [2,3] and minority variants
within the population of human immunodeficiency virus type 1
(HIV-1), including drug resistance [4,5,6,7,8,9], coreceptor use
[10,11,12] and coevolution in the nef gene [13]. The sequence
depth of the UDPS technology is limited by the experimental
error and the number of input template molecules. Experimental
errors may be introduced during the sequencing procedure [3] as
well as the preceding reverse transcription and PCR amplifica-
tion [9]. The PCR amplification is known to sometimes
generate: 1) Artifactual substitutions, insertions and deletions:
2) Primer mismatches that may result in selective amplification
f a i l u r eo fs o m es e q u e n c ev a r i a n t s( t h i si se s p e c i a l l yr e l e v a n tf o r
HIV-1 and other targets with high genetic variability [14] and
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amplification): and 3) In vitro recombination during PCR
amplification [15,16,17,18,19] that may disrupt mutational
linkage and thereby hinder studies of sequence variants. We
have previously shown that the in vitro recombination frequency
during UDPS is low [9], but here we extend these findings.
Bioinformatic approaches have been developed to distinguish
high confidence variants from sequencing artifacts. These
approaches have been reported to decrease the sequencing error
rate to levels ranging from 0.05% [9,20] to 0.43% [11]. The
error rate is not uniform across sites, but rather is higher in or
adjacent to homopolymer tracts [3]. Hence, we have suggested
that site-specific error rates should be used in studies of specific
mutations [9]. The repeatability of HIV-1 variant frequency
estimations using UDPS has been studied by Poon et al. [13],
who analyzed three patients’ plasma samples and showed that
the repeatability was high for variants representing more than 1–
5% of the virus population. Known variants representing 1%
[ 1 2 ]a n d0 . 1 %[ 2 0 ]h a v eb e e ns h o w nt ob ed e t e c t a b l eb yU D P S .
Comparison of UDPS data in forward and reverse direction
might facilitate data cleaning, but this has not been evaluated
previously.
In this study, we have amplified a region of the HIV-1 pol gene
of patients’ plasma samples and molecular clones to evaluate the
UDPS technology (FLX platform) for experimental noise and data
variability, such as repeatability, effects of sequence direction,
sensitivity, influence of primer-related selective amplification and
in vitro PCR recombination.
Materials and Methods
Ethics statement
A research ethics application was approved by Regional Ethical
Review Board in Stockholm, Sweden (Dnr 52/2008-77). The
patients gave written informed consent according to the
Declaration of Helsinki.
Samples
For this study, we used four HIV-1 patient plasma samples
(samples A, B, C and D). Sample A and B were used to study
repeatability, effects of sequence direction and influence of primer-
related selective amplification. These samples had approximately
1,050,000 and 1,600,000 HIV-1 RNA copies/ml, respectively.
Plasma samples C and D were used to generate two molecular
clones (clone 1 and clone 2) for studies on UDPS sensitivity and in
vitro PCR recombination. These two clones were chosen on the
basis of sequence dissimilarity with the aim to maximize the
number of informative sites in the pol amplicon of interest
(Figure 1).
Generation of molecular clones
A 1320 base pair fragment of the HIV-1 pol gene was amplified
with FastStart High Fidelity System (Roche, Penzberg, Germany)
using the primers JA269 and JA272 [9]. The amplicon was cloned
into a TOPO-TA cloning vector (Invitrogen, Carlsbad, California,
US) and chemically competent TOP10 cells were transformed
using heat. White colonies were picked and PCR amplified using
JA269 and JA272 and sequenced with Sanger sequencing using
Big Dye termination kit 3.1 (Applied Biosystems, Foster City,
California, US) according to the manufacturer’s instructions.
Ultra-deep pyrosequencing (UDPS)
We performed PCR amplification and UDPS on a 167 base
pair (bp) fragment of the HIV-1 pol gene as previously described
[9]. The data analysis was focused on a 120 bp fragment within
the amplicon, which corresponds to amino acid positions 180 to
219 of the reverse transcriptase (RT). Briefly, viral RNA was
extracted from 200 ml plasma using RNeasy Lipid Tissue Mini Kit
(Qiagen, Hilden, Germany) and [21] the QIAvac 24 vacuum
manifold (Qiagen, Hilden, Germany). cDNA synthesis was done
using primer JA272. The number of HIV-1 cDNA viral templates
subjected to UDPS was quantified using an in-house limiting
dilution PCR method [9].
Nested PCR was performed with outer primers JA269+JA272
followed by inner primers JA329+JA331 as previously described
[9]. The 59-ends of the forward and reverse inner primers included
the specific UDPS adaptors A and B, respectively, as well as 4-
nucleotide sample-specific tags, which were used to separate
sequence reads from different samples. The PCR amplicons were
purified using the GE PCR purification kit (GE health care,
Pollards Wood, United Kingdom) and the DNA concentrations
and purity were determined using Nanodrop (Thermo Fisher
Scientific, Waltham, US) and the Agilent 2100 Bioanalyzer
(Agilent Life Science, Santa Clara, California, US).
After quality controls, the PCR amplicons were sequenced in
both forward and reverse direction on the 454 Life Science
platform (GS-FLX, Roche Applied Science) according to the
manufacturer’s instructions. The two physical fields on the
Picotiter plate were used and eight samples were mixed and
analyzed in each field. We aimed at obtaining approximately
20,000 sequence reads from each sample. After UDPS, the read
from different samples were identified by in-house scripts and the
sample-specific sequence tags. The characteristics of the samples
and basic information about the UDPS are summarized in
Table 1.
Repeatability of variant quantification
The plasma samples A and B were analyzed two times each.
The RNA extraction, cDNA synthesis and PCR were performed
Figure 1. Nucleotide sequence alignment of clone 1 and clone 2. The clones cover position 3093–3206 in HXB2 and were used for the mixing
experiments. The clones differed by 13 informative sites that are highlighted in gray.
doi:10.1371/journal.pone.0022741.g001
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[9]. The number of input cDNA templates for sample A and B
were approximately 40.000 and 10.000, respectively.
Sensitivity of detecting minority variants
Clone 1 and clone 2 were used to generate two mixtures with
99.5:0.5 and 99.95:0.05 ratios. The two mixtures were used for
PCR amplification and UDPS. For both experiments we used
approximately 30,000 templates (determined using Nanodrop) as
input in the outer PCR reaction. We aimed at obtaining a total of
20,000 reads per sample. Thus, we attempted to detect 100 and 10
molecules, respectively, of the minor variant against a background
of approximately 20,000 molecules of the major variant.
Primer-related selective amplification
To determine the possible effect of selective amplification of
certain variants due to primer-related selective amplification,
plasma sample B was re-extracted and re-analyzed with an
alternative set of nested PCR primers, JA270+JA271 and
JA323+JA332, which amplify a 316-bp fragment that completely
encompasses the 167-bp region targeted by the first primer set.
None of the alternative primers overlapped with the original
primers. Both primer sets were designed to hybridize to conserved
regions of the HIV-1 pol gene and included wobbled bases to further
minimize the risk of selective amplification of certain viral variants.
WeperformedcDNAsynthesiswithJA271,CCACTAAYTTCTG-
TATRTCATTGAC (position 3309–3334 in HXB2) and a nested
PCR with outer primers JA271+JA270, GCTTCCCTCARAT-
CACTCTTA (position 2248–2268 in HXB2), and inner primers
JA323, TGGAAAGGATCACCAGCRATA (position 3006–3026
in HXB2) and JA332, GCTGTACTGTCCATTTRTCAGGATG
(position 3276-3252 in HXB2). The inner primers contained the
same UDPS adaptors and sample tags sequences as described
above. Both the outer and inner PCR cycling profiles were as
follows: 94uC for 2 min, 30 cycles of 94uC for 20 sec, 50uC for
20 sec and 72uC for 1 min 30 sec, followed by a final extension at
72uC for 6 min and finally at 4uC until used. The input number of
templates for UDPS was approximately 10,000 molecules.
Evaluation of in vitro PCR recombination
Clone 1 and clone 2 were mixed in a 50:50 ratio before PCR
amplification and UDPS. The clones differed by 13 informative
sites. We analyzed two mixtures with 100,000 and 10,000 DNA
templates (determined using Nanodrop, Thermo Fisher Scientific,
Waltham, US), respectively, as input in the outer PCR. A
recombinant was defined as a sequence that had replacement of at
least two signature nucleotides irrespective of whether they were
adjacent or not (Figure 1).
Data cleaning
The data cleaning was performed using in-house filtering scripts
(Jernberg et al., manuscript in preparation) as outlined previously
[9] and in Table S1. The data cleaning was designed to remove
reads with probable sequencing errors and was based on UDPS
analyses of an HIV clone. The filters used for each experiment and
the number of reads retained in each step are shown in Table S1.
Briefly, the scripts filter: 1) All reads with low similarity to the
corresponding Sanger sequence (in this study we used an 80%
similarity cut-off). 2) Reads that did not cover the entire region of
interest (amino acids 180–219 in RT). 3) Reads containing
ambiguous bases (Ns). Remaining reads were imported into the
GS amplicon software (Roche, Penzberg, Germany) and aligned.
4) The alignment was extracted and cut to the region of interest
(amino acid 180–219). The sequence data were compressed by
scripts that identified unique sequence variants in forward and
reverse direction and counted the number of reads per variant.
Additional scripts filtered: 5) Reads with out-of-frame indels or
stop codons while retaining reads with in-frame indels (i.e. 63, 6, 9
nucleotides). 6) The alignments were manually inspected and any
remaining variants with frameshifts or stop codons were removed.
7) In the experiments on patient plasma samples we used a
previously defined cut-off value (0.11% [0.09–0.21%]) for
detection of high-confidence variants [9]. Only the high-
confidence variants that were detected in both forward and
reverse direction were retained for further analysis. However, in
the experiment where the influence of sequence direction was
evaluated, we also assessed variants that only were observed in one
sequence direction.
Statistical analyses
We investigated repeatability of variant quantification using
Bland-Altman analyses and plots [22]. The number of reads per
variant was log transformed and the number of reads in the second
(repeat) measurement was weighted by the number of reads in the
first measurement. The Bland-Altman plot shows the average of
each paired measurement on the x-axis and the difference between
the paired measurements on the y-axis. The standard deviation
(SD) of all the individual differences is calculated as a measure of
repeatability. The limits of agreement are defined as the mean
difference 61.96 SD and represent the range within which
approximately 95% of the differences will lie if they are normally
Table 1. Characteristics of the samples and basic information on UDPS.
Experiment Sample and run characteristics Approx. no. of templates No. of UDPS reads after data cleaning
Repeatability Plasma A, run 1 40,000 26,846
Plasma A, run 2 40,000 23,376
Plasma B, run 1 10,000 14,614
Plasma B, run 2 10,000 11,934
Sensitivity Clone mix 0.5:99.5 30,000 23,668
Clone mix 0.05:99.95 30,000 25,622
Primer-related selective amplification Plasma B – alt. primers 10,000 8,858
In vitro recombination Clone mix 50:50 100,000 20,469
Clone mix 50:50 10,000 19,245
doi:10.1371/journal.pone.0022741.t001
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transformation). We also calculated 95% confidence intervals
(CI) of the limits of agreement according to Bland and Altman
[22]. In addition, we calculated variance-to-mean ratios to allow
comparisons with results published by Poon et al [13].
The difference between the number of recombinant variants in
the 10,000 and 100,000 template experiments was compared using
chi-square statistics. We compared the number of unique variants,
rather than the total number of recombinant reads, since each
recombinant will be PCR amplified and therefore may appear in
one or several reads depending on in which PCR cycle they were
generated.
Results
The data cleaning was performed in a hierarchical manner by
an in-house method (Jernberg et al., manuscript in preparation) as
outlined previously [9]. During this process we discarded on
average 20% (range 8–34%) of the reads per sample. Detailed
information on the cleaning procedure and the number of reads
retained after each cleaning step is shown in Table S1.
High repeatability of variant quantification
To evaluate the repeatability of frequency estimates of HIV-1
variants using UDPS, we repeated the complete experimental
protocol for two patient plasma samples (sample A and sample B).
Thus, these experiments evaluated the repeatability of the RNA
extraction, cDNA synthesis and PCR. The analyses of repeat-
ability were done on ‘‘high-confidence’’ variants, which had been
identified using a data cleaning procedure that removed probable
sequencing artifacts (see Materials and Methods and [9]). For
sample A, a total of 27 variants were detected in both run A:1
and run A:2. The least abundant variant that was detected in
both runs represented on average 0.11% of the viral population
(Table 2). In addition, there were six high-confidence variants
that were unique to run A:1, i.e. not detected in run A:2. These
unique variants represented between 0.11 and 0.23% of the
population. Similarly, there were four unique variants in run A:2
that represented between 0.12% and 0.13% of the population. In
sample B, 15 variants were identified in both run B:1 and run B:2
and the least abundant variant represented on average 0.17% of
the population (Table 2). In addition, eight unique variants were
found in run B:1 (representing between 0.15 and 0.27%) and
seven unique variants were found in run B:2 (representing
between 0.12 and 0.21%).
Figure 2 shows a Bland-Altman plot of the repeatability of
quantification of virus variants in sample A and B [22]. Individual
Bland-Altman plots of sample A and sample B gave similar results
(data not shown). The mean log10 difference between the two
measurements was 20.02 (95% CI: 20.08–0.05). The upper limit
of agreement was 0.39 (95% CI: 0.22–0.50) and the lower limit of
agreement was 20.42 (95% CI: 20.53–20.31). This means that a
repeated measurement would have a 95% likelihood to lie
approximately within a factor 60.5 log10 of the initial estimate.
Thus, a variant that was found in 100 reads in the first
measurement had a 95% likelihood to lie between 32 and 320
reads in the second measurement. Somewhat unexpectedly there
was no relationship between the repeatability of quantification and
the abundance of the variants (Spearman R=20.054, p=0.73).
In a previous publication Poon et al. [13] investigated UDPS
repeatability by calculations of the variance-to-mean ratios. To
allow comparison with these results we did similar calculations.
The variance-to-mean ratio for sample A ranged from 2.5610
22
to 4.7610
27 and had a median value of 1.1610
24. For sample B,
the variance-to-mean ratios ranged from 5.9610
22 to 6.7610
26,
with a median value of 8.2610
24. The average variance-to-mean
ratio in the two experiments was 3.2610
24.
We also investigated the agreement of quantification in forward
vs. reverse reads for the 27 and 15 variants observed in sample A
and sample B, respectively. A Bland-Altman analysis of the
combined data from the repeated measurement of sample A and
sample B showed that the mean log10 agreement between the
forward and reverse measurements was 0.03 (95% CI: 20.01–
0.08) (Figure 3). The upper limit of agreement was 0.35 (95% CI:
0.26–0.43) and the lower limit of agreement was 20.28 (95% CI:
20.36–20.20). This is similar to the repeatability in the re-analysis
experiments described above. However, in contrast to these
experiments, the agreement between forward and reverse analyses
was higher for common variants than for rare variants (Spearman
R=0.63, p,0.001). We also studied variants that were found only
in one direction (forward or reverse). Together these variants
represented on average 3.8% (range 2.0 to 4.9%) of the total
amount of reads in each direction, but all such variants were rare
and constituted between 0.07 and 0.19% of the virus population
(Table S2).
Collectively these results showed that we were able to detect
viral variants that represented down to 0.11% of the virus
population. The repeatability was good for both major and minor
variants. Thus, the experimental noise introduced during the RNA
extraction, cDNA synthesis and PCR was low. However, there was
Table 2. Limit of detection of repeatedly detected virus variants in samples analyzed using original primers and alternative PCR
primers.
Sample
No. of variants
detected in both runs
Lowest proportion (%) of variants
detected in both runs (run 1, run 2)
Highest proportion (%) of variants
detected in only one run
Plasma A, run 1 27 0.11 (0.11, 0.11) 0.23
0.13
Plasma A, run 2
Plasma B, run 1 15 0.17 (0.18, 0.16) 0.27
0.21
Plasma B, run 2
Plasma B, run 1 14 0.19 (0.16, 0.21) 0.40
0.34
Plasma B – alt. primers
doi:10.1371/journal.pone.0022741.t002
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detect rare variants.
Minority variants can be detected
The error frequency of our experimental system has previously
been shown to be 0.11% (range 0.09–0.21%) at the variant level
[9], which means that theoretically it should be possible to detect
a single molecule of one variant against a background of
approximately 1000 molecules representing other variants. In
line with this the repeated UDPS analyses of plasma samples A
and B above indicated that minority variants constituting
.0.27% could be detected and reproducibly quantified. To
further investigate the lower limit of detection of viral variants we
performed UDPS on two molecular clones that had been mixed
at ratios of 99.5:0.5 and 99.95:0.05. In the first experiment (ratio
99.5:0.5) we obtained 23,668 reads of which 524 (2.2%) were the
minority variant. In addition, 21 recombinant reads were
identified, corresponding to 0.089%. In the second experiment
(ratio 99.95:0.05), 79 (0.31%) of the total 25,622 reads were
found to be the minority variant. Here, we only identified a single
recombinant sequence read, representing 0.0039% of the total
population. These data suggest that minor HIV-1 variants that
constitute as little as 0.05% of the viral population can be
detected by UDPS, but we cannot rule out the possibility that our
artificial mixtures contained slightly higher proportions of the
minor virus variant than intended.
Potential selective PCR amplification as a result of primer
mismatch
The effect of primer design was evaluated by re-extracting
sample B and performing cDNA and PCR with an alternative set
of nested primers. Fourteen high-confidence variants were found
in both experiments and the least abundant variant represented
0.19% of the population (Table 2). In addition, 12 variants
(representing between 0.15 and 0.40%) were only found when the
original primer set was used and eight variants (representing
between 0.12 and 0.34%) were only found when the alternative
primer set was used. Figure 4 shows a Bland-Altman plot of the
agreement of variant frequency estimates using the two primer
sets. The mean log10 difference between the forward and reverse
measurements was 20.12 (95% CI: 20.34–0.09). The upper limit
of agreement was 0.64 (95% CI: 0.26–1.01) and the lower limit of
agreement was 20.89 (95% CI: 20.51–21.26). Thus, the limits of
agreement were approximately two times wider than when UDPS
was repeated with the same primers. The main reason for this
difference was that a single variant, which represented 46% of the
virus population in the analyses with the original primers, only
represented 5.6% in the analysis with the alternative primers
(outlier marked by an arrow in Figure 4). This suggests that this
particular variant was selectively under-quantified by the alterna-
tive primers, presumably due to a primer mismatch problem.
Since it was a major variant the estimates of the proportions of all
other variants were also affected. Accordingly, the agreement
Figure 2. Bland-Altman plot showing the repeatability of variant quantification using UDPS. UDPS was performed twice for sample A
and sample B. These paired measurements were combined and the number of reads in the second (repeat) measurement was weighted by the
number of reads in the first measurement. The number of reads per variant was log transformed. The differences in number of reads per variant in the
repeat analyses are plotted against the average number of reads per variant. Horizontal lines are drawn at the mean difference between the two
measurements and at the upper and lower limits of agreement. The 95% confidence intervals are also shown for the mean and the upper and lower
limits of agreement.
doi:10.1371/journal.pone.0022741.g002
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higher if the problematic variant was omitted (data not shown).
Low level of in vitro recombination
UDPS has been used to study genetic variants and mutational
linkage, but such analyses are only valid if the frequency of in vitro
recombination is zero or low. To determine the in vitro
recombination frequency in our experimental system we mixed
two molecular clones in a 50:50 ratio before PCR amplification
and UDPS. The two clones differed by 13 informative sites that
were distributed over the fragment (Figure 1). In addition, to study
if the frequency of in vitro PCR recombination may be influenced
by the number of target molecules we tested both 100,000 and
10,000 HIV DNA templates as input in the outer PCR.
In the experiment where 100,000 input HIV DNA templates
were used, we identified 182 recombinant reads among a total
20,469 reads, which corresponds to an in vitro recombination
frequency of 0.89%. Based on the signature nucleotides, the
recombinant reads consisted of 12 single recombinants, which
represented between 0.005 and 0.25% of all reads, and four double
recombinants, which represented 0.005% each (Figure 5A). When
10,000templateswereused asinputwefound56recombinantreads
among a total 19,245 reads, which corresponds to a recombination
frequency of 0.29%. There were 10 single recombinants (repre-
senting between 0.005 and 0.07%) and two double recombinants
(representing 0.01% and 0.005%) (Figure 5B). In the experiment
with 100,000 and 10,000 input molecules, we identified a few
possible triple and quadruple recombinants ranging from 0.005 to
0.01% (Figure 5A and Figure 5B). However, it is difficult to
determine if these reads have been generated by recombination,
substitution or a combination of both. The difference between the
numbers of recombinant variants in the 100,000 template
experiment compared the 10,000 template experiment was not
statistically significant (p=0.47, chi-square test). Taken together,
these results showed that the in vitro recombination frequency was
low in our experimental system, which allows us to study mutational
linkage and identify genetic variants.
Discussion
In this study we have evaluated the sensitivity, repeatability,
primer-related selective amplification and in vitro PCR recombi-
nation of a UDPS protocol that targets a 120 base pair fragment of
the HIV-1 pol gene. We found that our system was capable of
delivering repeatable results for variants representing .0.27% of
the population. The repeatability of quantification of viral variants
was approximately 60.5 log. A similar degree of agreement was
observed between forward and reverse reads. Furthermore, our
results indicate that the choice of primers may be important when
analyzing highly variable sequences, like HIV-1, due to the risk of
primer-related selective amplification. Finally, the in vitro recom-
bination rate during PCR was low, suggesting that our UDPS
Figure 3. Bland-Altman plot showing the agreement of variant quantification in forward and reverse direction. The data from the
paired measurements from sample A and sample B were combined and the number of reads in the reverse direction was weighted by the number of
reads in the forward direction. The number of reads per variant was log transformed. The differences in number of reads per variant in forward and
reverse direction are plotted against the average number of reads per variant. Horizontal lines are drawn at the mean difference between the two
measurements and at the upper and lower limits of agreement. The 95% confidence intervals are also shown for the mean and the upper and lower
limits of agreement.
doi:10.1371/journal.pone.0022741.g003
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PLoS ONE | www.plosone.org 6 July 2011 | Volume 6 | Issue 7 | e22741Figure 4. Bland-Altman plot showing the agreement of variant quantification using two primer sets. Templates for UDPS were prepared
using original and alternative PCR primers. The number of reads in the second (alternative primers) measurement was weighted by the number of
reads in the first measurement. The number of reads per variant was log transformed. The differences in number of reads per variant using the two
primer sets are plotted against the average number of reads per variant. Horizontal lines are drawn at the mean difference between the two
measurements and at the upper and lower limits of agreement. The 95% confidence intervals are also shown for the mean and the upper and lower
limits of agreement.
doi:10.1371/journal.pone.0022741.g004
Figure 5. Analysis of in vitro PCR recombination. The informative sites of clone 1 and clone 2 (see Figure 1) are shown in italics in the upper part
of the figure. Below are identified recombinant reads presented for the experiment with 100,000 input template molecules (panel A) and 10,000 input
template molecules (panel B). The proportion (Prop. %) of each recombinant is also shown.
doi:10.1371/journal.pone.0022741.g005
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linkage.
To evaluate the repeatability of frequency estimates of HIV
variants, we performed repeated UDPS analyses of two patient
plasma samples. We found that a repeated measurement would
have a 95% likelihood of lying within 60.5log10 of the initial
estimate. Interestingly, the repeatability was similar for rare and
more abundant variants. We also compared our results with those
of Poon et al. [13], who used variance-to-mean ratios to investigate
repeatability. The average variance-to-mean ratio in our exper-
iments was 3.2610
24, which is more than 20 times lower than that
estimated by Poon et al. [13]. In addition, they reported that some
variants that represented 1–5% of the virus population in one
analysis were not detected when the analysis was repeated.
Similarly, Gianella et al. recently reported a low level of
repeatability in detection and quantification of minority drug
resistance mutations [23]. We repeatedly identified all variants
that represented .0.27% of the virus population. The reason for
the differences in repeatability between these studies and ours is
not clear, but could be due to differences in both laboratory
methodology, sequencing approach and data cleaning. For
instance Gianella et al. used a shotgun sequencing approach,
which generally gives lower sequence depth (coverage) than
amplicon sequencing. In summary, we found that our system had
good repeatability, which indicates that the experimental noise
introduced during RNA extraction, cDNA synthesis, PCR and
UDPS was low. However, and as illustrated above, the
performance of our UDPS system cannot be directly translated
to other UDPS systems, since both the error rate and the
reproducibility depends on many factors such as experimental
methodology, amplicon length, UDPS platform and data cleaning
strategy. Furthermore, our cleaning strategy has been optimized
for this amplicon, but the filters and their settings can be changed
by the user to obtain a less stringent data cleaning if desired. In
fact, we recommend that each step in the cleaning process should
be optimized for each gene region analyzed and according to the
purpose of the analyses.
Analysis of bidirectional UDPS has been described in only a few
studies [9,11,24], in which variants were considered ‘‘true’’ if they
were present in both sequence directions. Here, we have studied
the effect of sequence direction on variant abundance estimates.
We found that the difference in variant abundance between
forward and reverse sequence direction was relatively small and
approximately as great as the difference between UDPS runs.
However, in contrast to these experiments, the agreement between
forward and reverse analyses was higher for common variants than
for rare variants. In addition, some variants only exceeded our cut-
offs for high-confidence variants in one sequence direction. These
variants would be considered ‘‘true’’ if sequencing was done in
only one direction (forward or reverse) or if the requirement that a
variant need to be present in both forward and reverse direction
would be ignored. It is not surprising that there is some
stochasticity in the ability to detect rare variants that have an
abundance that is close to the detection limit.
We tested the ability of our UDPS methodology to identify
minority variants representing 0.5 and 0.05% of the population
using mixing experiments of molecular clones. The minor variant
was identified in both experiments, but the proportions were
somewhat higher than intended, i.e. 2.2% and 0.31% respectively.
This may be a stochastic effect, but we cannot exclude the
possibility that minority strains may have been systematically
overestimated for instance if major variants have reached the PCR
plateau earlier than rare variants. Artificial HIV-1 mixtures of 1%
and 0.1% have been analyzed by Tsibris et al. [12] and Zagodi
et al. [20], respectively. Our results are in agreement with those by
Tsibris et al. and Zagordi et al., and suggest that it is possible to
detect minor variants of the HIV-1 population, at least when the
minor variant is genetically clearly distinguishable from the major
variants such as in the case of superinfections.
We also evaluated the potential influence of primer-related
selective amplification on estimation of variant abundance using
alternative primer sets that targeted the same region in the pol
gene. Despite our efforts to design two optimal sets of nested
primers that targeted highly conserved primer binding sites and
included wobbled nucleotides, the estimations of variant abun-
dance differed between the two primer sets. We were able to detect
variants down to 0.2% of the viral population with both primer
sets. However, one variant, which was estimated to represent 46%
using the original primers, was detected in only 5.6% of the reads
obtained with the alternative primers. As a result the limits of
agreement was approximately two times wider than when the
sample was re-analyzed with the original primer set. This suggests
differential amplification of certain HIV-1 variants, presumably
due to primer- related selective amplification. Thus, optimal
primer design may be very important when UDPS is used to
analyze the population structure in divergent target sequences, like
HIV-1 populations. One could even speculate if multiple primer
sets should be used in order to fully and correctly characterize
HIV-1 variation.
We found that the frequency of in vitro recombination was
0.89% and 0.29% when 100,000 and 10,000 templates were used
as input, respectively. Most recombinants were represented by a
very low number of reads and most of these variants would be
removed by our data cleaning strategy since their abundances
were lower than our cut-off for high-confidence variants (0.11%)
[9]. The frequency of in vitro recombination that we estimated was
higher than reported by Tsibris et al. [12] (0.11 to 0.15%) but
lower than that reported by Zagordi et al. [20](1.9%). However,
while we used 50:50 clonal mixtures, Tsibris et al. used an 89:10:1
mixture and the likelihood of in vitro recombination during PCR
should be higher with 50:50 mixtures. The higher in vitro
recombination frequency reported by Zagordi et al., who used a
mixture of 10 clones in proportions of 0.3 to 30%, is probably due
to a longer amplicon, but could also be due to differences in
laboratory methodology or data cleaning strategies. It is likely that
most in vitro recombinants are generated during PCR and
consequently in vitro recombination frequency will probably
increase if larger amplicons are analyzed. This is relevant when
longer amplicons are analyzed using the Titanium platform that
can analyze up to 500 bp long fragments and future platforms that
will be able to analyze even longer fragments. However, it may be
possible to reduce PCR-induced recombination by lowering the
cycle number, increasing the extension time and decreasing the
initial template concentration [16,17,19,20]. Furthermore, the
choice of DNA polymerase may be of importance [20]. Here, we
have shown that in vitro recombination is low for our PCR
methodology. However, we found individual recombinants
representing up to 0.25% of the population, which implies that
in vitro recombination cannot be excluded for rare variants.
One limitation of this study should be recognized. The number
of samples included in the study was limited and some of the
experiments were not repeated. However, we believe the results
show the capacity of our UDPS system and the results also
highlight the importance of including control experiments in
UDPS studies.
In conclusion, we have performed a series of experiments to
evaluate the performance of UDPS analysis of a region of the
HIV-1 pol gene. The results show that the repeatability was good
Performance of Ultra-Deep Pyrosequencing
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rare variants in vitro recombination and effects of sequence
direction needs to be considered. Finally, the design of primers
for PCR amplification is of special importance during UDPS, since
primer-related selective amplification can skew frequency esti-
mates of genetic variants. The results are of relevance for future
research and clinical use of the UDPS technology.
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